BRIEF published on 04/22/2026 at 09:09, 15 days 15 hours ago Marinomed Biotech AG se développe dans le domaine des services de préparation magistrale Expansion Mondiale Technologie Marinosolv Biotechnologie Marinomed Services De Préparation Magistrale Médicaments Personnalisés
BRIEF published on 04/22/2026 at 09:09, 15 days 15 hours ago Marinomed Biotech AG Expands into Compounding Services Global Expansion Marinomed Biotech Marinosolv Technology Compounding Services Customized Medicines
PRESS RELEASE published on 04/22/2026 at 09:04, 15 days 15 hours ago Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology Marinomed Biotech AG announces strategic expansion into compounding services with Marinosolv technology, offering personalized medicines for global demand Marinomed Biotech AG Strategic Expansion Marinosolv Technology Compounding Services Personalized Medicines
BRIEF published on 04/13/2026 at 17:07, 24 days 7 hours ago Marinomed Biotech AG Completes Successful Capital Increase Capital Increase Investor Confidence Vienna Stock Exchange Marinomed Biotech Shares Issued
BRIEF published on 04/13/2026 at 17:07, 24 days 7 hours ago Marinomed Biotech AG finalise avec succès son augmentation de capital Augmentation De Capital Confiance Des Investisseurs Bourse De Vienne Actions Émises Biotechnologie Marinomed
PRESS RELEASE published on 04/13/2026 at 17:02, 24 days 7 hours ago Marinomed secures financing through successful capital increase Marinomed Biotech AG successfully completes capital increase, securing EUR 2.23 million in gross proceeds. Financing to support company's milestones and flagship products marketing Financing Capital Increase Marinomed Biotech AG Rights Offering Marinosolv Technology
BRIEF published on 03/23/2026 at 17:49, 1 month 15 days ago Marinomed Biotech AG: Capital Increase and 2025 Financial Outlook Capital Increase Marinomed 2025 Results Liquidity Gap Shareholder Opportunity
BRIEF published on 03/23/2026 at 17:49, 1 month 15 days ago Marinomed Biotech AG : Augmentation de capital et perspectives financières pour 2025 Augmentation De Capital Marinomed Résultats 2025 Déficit De Liquidités Opportunité Pour Les Actionnaires
PRESS RELEASE published on 03/23/2026 at 17:44, 1 month 15 days ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research issues a Buy recommendation with a target price of EUR 50 for Marinomed Biotech AG due to a capital increase and delayed Carragelose earn-out revenues First Berlin Equity Research Buy Recommendation Capital Increase Marinomed Biotech AG Carragelose Earn-out
BRIEF published on 03/19/2026 at 16:52, 1 month 19 days ago Marinomed Biotech lance une augmentation de capital par souscription de droits Augmentation De Capital Biotechnologie Marinomed Droits D'abonnement Perspectives Budgétaires Déficit De Liquidités
Published on 05/08/2026 at 00:00, 37 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 1 hour 7 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 1 hour 22 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 2 hours 32 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 2 hours 32 minutes ago Innodata Reports Record First Quarter 2026 Results
Published on 05/07/2026 at 23:23, 1 hour 13 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 1 hour 22 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 32 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 3 hours 54 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 5 hours 51 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 5 hours 22 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 5 hours 22 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 31 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 31 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 5 hours 37 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
